<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>
U.S.-listed shares of Sanofi SNY, +0.37% gained 0.4% in trading on Friday after it announced that co-administering a flu shot with Moderna Inc.’s MRNA, -3.33% experimental COVID-19 booster in seniors is safe and effective. Moderna’s stock was down 2.7%.
...read full article on Market Watch
